| CITATION: | Pharmacy Board of Australia v Donnelly [2011] QCAT 584 |
| PARTIES: | Pharmacy Board of Australia (Applicant/Appellant) |
| v | |
| Alison May Donnelly (Respondent) |
| APPLICATION NUMBER: | OCR270-10 |
| MATTER TYPE: | Occupational regulation matters |
| HEARING DATE: | On the papers |
| HEARD AT: | Brisbane |
| DECISION OF: | Judge Fleur Kingham, Deputy President Assisted by: Ms Kerrie Kensell Dr Margaret Shapiro Ms Karin Walduck |
| DELIVERED ON: | 22 November 2011 |
| DELIVERED AT: | Brisbane |
| ORDERS MADE: | 1. Ms Donnelly’s registration is suspended for six months. 2. The suspension order is wholly suspended, provided that Ms Donnelly must not be subject to disciplinary action by the Tribunal for twelve months from the date of this order. 3. The following conditions must be imposed on Ms Donnelly’s registration: 3.1 Ms Donnelly must complete a tertiary module in ethical decision-making. 3.2 Ms Donnelly must nominate a course for the approval of the Board. 3.3 Ms Donnelly must submit documentary evidence to the Board upon completion of the course. 3.4 Ms Donnelly must undergo mentoring for not less than 2 hours per month for 6 months. The mentoring should focus upon ethical decision-making in a dispensing environment and strategies to resist pressure to inappropriately dispense. 3.5 Ms Donnelly must nominate a mentor for the approval of the Board, who must be a practising pharmacist who is senior to her in age and experience. 3.6 The mentor must provide a report in writing to the Board at the end of each quarter and upon completion of the period of mentoring. 3.7 Ms Donnelly must bear any costs associated with the provision of mentoring including the provision of reports to the Board. 3.8 Ms Donnelly must complete the Australian Pharmacy Competency Assessment Tool administered by the Australian Pharmacy Council Ltd at the end of the period of suspension. 4. Ms Donnelly may not apply for reinstatement of her endorsement under the Health (Drugs and Poisons) Regulation 1996 s 171 for Testosterone, Nandralone and Somatropin for 12 months from the date of this order. 5. Ms Donnelly must pay the Board’s costs of and incidental to these proceedings fixed in the sum of $15,000, within 45 days of the date of this order. |
| CATCHWORDS: | HEALTH – PHARMACIST – DISCIPLINARY PROCEEDINGS – where pharmacist dispensed anabolic steroids in quantities, combinations and frequency that well exceeded normal dispensing practices – where young pharmacist who received no personal benefit – where parties agreed on the orders that should be made Health (Drugs and Poisons) Regulation 1996 s 64 |
APPEARANCES and REPRESENTATION (if any):
This matter was heard and determined on the papers pursuant to s 32 of Queensland Civil and Administrative Tribunal Act2009 (QCAT Act).
REASONS FOR DECISION
Ms Donnelly graduated as a pharmacist in 2004. These proceedings involve her practice as a pharmacist in Gladstone, between July 2008 and March 2009. In that period, Ms Donnelly dispensed the following anabolic steroids to a single customer:
a)84 Deca-Durabolin ampoules;
b)138 Primoteston Depo ampoules;
c)1350 Proviron tablets; and
d)126 Sustanon ampoules.
Such medications have the potential for misuse and abuse. It…
Keep reading for free
Create a free CaseChat account to read Pharmacy Board of Australia v Donnelly and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2011] QCAT 584
- Decision Date
CaseChat Overview and Summary
In reaching its decision, the court emphasised the importance of ethical standards in the pharmacy profession and the need to protect public health. The court found that Ms Donnelly's actions did indeed constitute professional misconduct. However, it took into account the agreed terms between the parties regarding the appropriate sanctions. The court accepted that Ms Donnelly had not acted for personal gain and had cooperated fully with the proceedings. The court imposed a six-month suspension of Ms Donnelly's registration, which was wholly suspended contingent on her not facing further disciplinary action for twelve months. Additionally, the court mandated a series of educational and mentoring requirements to ensure Ms Donnelly's future compliance with ethical standards. These included completing a tertiary module in ethical decision-making, undergoing mentoring for six months, and submitting reports to the Board.
The court also ordered that Ms Donnelly could not apply for reinstatement of her endorsement for certain substances for twelve months and had to pay the Board's costs of $15,000 within 45 days. The court's decision balanced the need for deterrence with the opportunity for rehabilitation, reflecting the agreed terms and the principles of justice and proportionality.
Orders
Orders of the court
1. Ms Donnelly’s registration is suspended for six months.
2. The suspension order is wholly suspended, provided that Ms Donnelly must not be subject to disciplinary action by the Tribunal for twelve months from the date of this order.
3. The following conditions must be imposed on Ms Donnelly’s registration:
3.1 Ms Donnelly must complete a tertiary module in ethical decision-making.
3.2 Ms Donnelly must nominate a course for the approval of the Board.
3.3 Ms Donnelly must submit documentary evidence to the Board upon completion of the course.
3.4 Ms Donnelly must undergo mentoring for not less than 2 hours per month for 6 months. The mentoring should focus upon ethical decision-making in a dispensing environment and strategies to resist pressure to inappropriately dispense.
3.5 Ms Donnelly must nominate a mentor for the approval of the Board, who must be a practising pharmacist who is senior to her in age and experience.
3.6 The mentor must provide a report in writing to the Board at the end of each quarter and upon completion of the period of mentoring.
3.7 Ms Donnelly must bear any costs associated with the provision of mentoring including the provision of reports to the Board.
3.8 Ms Donnelly must complete the Australian Pharmacy Competency Assessment Tool administered by the Australian Pharmacy Council Ltd at the end of the period of suspension.
4. Ms Donnelly may not apply for reinstatement of her endorsement under the Health (Drugs and Poisons) Regulation 1996 s 171 for Testosterone, Nandralone and Somatropin for 12 months from the date of this order.
5. Ms Donnelly must pay the Board’s costs of and incidental to these proceedings fixed in the sum of $15,000, within 45 days of the date of this order.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi